Mazabraud syndrome is an association between fibrous dysplasia and intramuscular myxomas, first described in 1926 by Henschen [1] and later by Mazabraud and Girard [2] . The syndrome has a mean presenting age of 46, with a range of 17-82. Roughly 70 % of cases are in women [3] . A review of 80 previous cases showed that 26 (33 %) had an association with McCune-Albright syndrome [4] . A recent case demonstrated the typical findings of this association: polyostotic fibrous dysplasia, multiple myxomas, brown-pigmented areas of the skin, and endocrine dysfunction [5] .
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Fibrous dysplasia is caused by a mutation to guanine nucleotide-binding protein, a-stimulating activity polypeptide 1 (GNAS1) [6] , which encodes a protein involved in cell proliferation activity. The process is characterized by replacement of bone marrow by fibro-osseous tissue [7] , may be mono-or polyostotic and is commonly unilateral.
Histologically, affected bones classically shows thin, irregular trabeculae and fibrotic marrow space, resembling Chinese lettering. It has an extremely varied radiological appearance on plain radiographs and CT, with ground-glass opacities, lucent foci or sclerotic areas. There may be bone deformity, expansion or endosteal scalloping. The polyostotic form of fibrous dysplasia predominates [8] and is most commonly seen in the femur and pelvis.
Myxomas are benign neoplasms that present in the 6th or 7th decade of life. In Mazabraud syndrome, they are usually diagnosed after or at the same time as fibrous dysplasia [9] . The myxomas are often multiple (70 % of cases) and noncontiguous with bone, although often found in close proximity with the area of fibrous dysplasia, as in the case presented here. Lesions have a predilection for the lower limbs. In Mazabraud syndrome, fibrous dysplasia is monostotic in 20 % of cases, and polyostotic in 80 % [9] . They are frequently asymptomatic, and patients may only present when the lesions are large enough to cause pain, restrict movement or cause vascular or neural impingement due to local mass effect. Our patient presented on noticing a large palpable mass in her vastus medialis muscle. A second smaller mass in vastus intermedius was not palpable.
Histopathologically, myxomas show bipolar and bland stellate fibroblasts separated by extracellular myxoid matrix. A diagnosis is strongly suggested if the lesions demonstrate typical myxoid MRI findings, including high water content, modest surrounding oedema and minimal surrounding fat atrophy. They are well-circumscribed low signal on T1-weighted images and high signal on T2-weighted images. In circumstances where these features are found in association with fibrous dysplasia, biopsy would not be required.
As there have been five reported cases of malignant change of fibrous dysplasia [10] and approximately 22 % of patients require surgery following pathological fracture [9] , repeat imaging is advised if there are recurrent or new symptoms. Myxomas should be excised only if patients are symptomatic.
The combination of fibrous dysplasia and myxomas in Mazabraud syndrome is rare and likely to be under-diagnosed, and the risk of malignant transformation requires a high level of suspicion for the condition. Mazabraud syndrome has also been associated with uterine fibromas and adenofibromas, pagetoid skull, hamartomas and lipoma [5] . Mazabraud syndrome should be considered when patients present with any of these pathologies or associated conditions such as McCuneAlbright syndrome.
